This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Tuesday's Late Winners & Losers

The most heavily traded stocks were mixed after the closing bell Tuesday, and leading the winners by a wide margin was San Diego-based biotech Cypress Bioscience (CYPB).

Shares rocketed 87.1% to $15.81 in extremely heavy trading after it and Forest Laboratories (FRX) announced positive results from a late-phase trial.

The companies said that milnacipran, which is already approved to treat depression, showed statistically significant results in treating fibromyalgia syndrome -- a chronic and painful condition that causes stiffness, severe fatigue and insomnia. Forest shares jumped 8.2% to $56.15.

Aluminum-products makers Alcan (AL) and Alcoa (AA) were up more than 2.5% each after Alcan's board unanimously rejected the latter's recent hostile takeout bid, worth roughly $27 billion in cash and stock.

Shanda Interactive Entertainment (SNDA), a China-based online-games developer, rose 3.4% to $29.60 after earning 36 cents per American depositary share (non-GAAP) in the first quarter. This is 7 cents higher than the average Wall Street estimate, according to Thomson Financial.

Minneapolis medical-equipment maker Medtronic (MDT) climbed 3.3% to $52.47 after coming in 4 cents above the mean target with non-GAAP earnings of 66 cents a share, or $767 million, in the quarter ended April 27.

Semiconductor maker Advanced Analogic Technologies (AATI) of Sunnyvale, Calif., was also on the rise after announcing it had "prevailed" in a patent-infringement case brought by Linear Technology (LLTC). AnalogicTech said all of Linear's claims were found "either non-infringed or invalid" in an "initial determination" by the International Trade Commission. The final determination should issue by Sept. 22. Linear, for its part, traded down 1% to $36.77 in recent extended trading.

Among others on the postclose downswing, Analog Devices (ADI) fell after predicting fiscal third-quarter income of 37 cents to 41 cents a share (excluding items) on sales ranging between $655 million and $685 million, which leans to the lower end of consensus. The Norwood, Mass., semiconductor company bested targets for the quarter ended May 5, but shares still slid 6% to $38.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,805.41 +127.51 0.76%
S&P 500 1,964.58 +13.76 0.71%
NASDAQ 4,483.7150 +30.9230 0.69%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs